Live Breaking News & Updates on Pooled safety analysis through

Stay updated with breaking news from Pooled safety analysis through. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Janssen Presents Study Results Showing Clinical Efficacy for TREMFYA® (guselkumab) and Long-Term Safety Profile for STELARA® (ustekinumab) for Patients Living with Inflammatory Bowel Disease at Di...

New data show proportions of patients treated with TREMFYA who achieved clinical-biomarker response ranged from 47.5-66.7 percent across dose grou. ....

United-states , Japan , Calgary , Alberta , Canada , California , San-diego , Spring-house , British-columbia , Horsham , Saskatchewan , Americans

Janssen Presents Results of First Head-to-Head Study of Biologic Therapies in Patients with Moderate to Severe Crohn's Disease

/PRNewswire/ The Janssen Pharmaceutical Companies of Johnson & Johnson today announced efficacy and safety data for STELARA® (ustekinumab) in Crohn s. ....

United-states , Americans , American , Pbruce-sands , Jennifer-mcintyre , Christopher-delorefice , Burrillb-crohn , Brucee-sands , Jan-wehkamp , Bridget-kimmel , American-society-for-gastrointestinal-endoscopy , Crohn-colitis-foundation